Market by Component (Storage, Transportation, Monitoring components), Pharma Type (Branded Drugs, Generic Drugs, OTC), Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas), Logistics Type (Non-Cold Chain Logistics, Cold Chain Logistics) and Country Outlook | Forecast 2024-2032
Triton’s research report denotes that the North America pharmaceutical logistics market is expected to witness revenue growth at a CAGR of 7.81% during the forecast period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The growth in pharmaceutical sales is a primary driver of the pharmaceutical logistics market in North America. Additionally, the rising geriatric population in the region has led to an increase in chronic diseases, spurring demand for modern healthcare products and services. As per estimates, the population aged 65 and over is expected to grow to 22% by 2040 in the US. This trend necessitates a robust infrastructure for the safe and secure transportation of pharmaceutical products, thereby creating demand for pharmaceutical logistics services.
The countries given in this region include:
The United States spearheads the regional market, reaching $26881.12 million by 2023.
American pharmaceutical companies allocate approximately 21% of their revenues to R&D. Hence, the United States has emerged as a dominant force in the global pharmaceutical sector, accounting for about half of total global sales.
Pharmaceutical distributors play a crucial role in the US market, handling around 92% of pharmaceutical sales. They streamline a complex supply chain that links over 1,300 manufacturers with more than 180,000 points of dispensation.
The biopharmaceutical industry is increasingly outsourcing shipping and distribution processes to 3PL pharmaceutical logistics providers. The regulatory landscape has also become more stringent, prompting a shift towards electronic tracking systems that offer real-time updates.
Innovations in cold storage technology are also driving the pharmaceutical logistics industry’s growth. For instance, in July 2020, Wabash National Corporation introduced refrigerated inserts from Gruau for its cold storage transportation solutions.
Market Forecast for Canada
Pharmaceuticals are a significant part of healthcare spending in Canada, accounting for around 15% of the total health expenditures. While pharmaceutical spending continues to rise, the growth rate has slowed across provinces and territories. In 2020, the United States accounted for 64% of Canadian pharmaceutical exports and 29% of its imports.
Canada’s domestic pharmaceutical industry comprises about 140 companies, more than 50 of which are research-based. Over half of the country’s pharmaceutical production is exported, predominantly to the US. A major growth driver is the increasing use of biologics, which also significantly fuels the expansion of the pharmaceutical logistics industry.
The market report is sectioned based on therapy area, pharma type, logistics type, and component. The therapy area is further divided into diabetes, communicable diseases, oncology, autoimmune diseases, pain management, cardiovascular diseases, respiratory diseases, neurological disorders, and other therapy areas.
Type 2 diabetes is the most prevalent form of diabetes, comprising over 90% of cases globally. Cancer is also widespread, with the International Agency for Research on Cancer (IARC) estimating that one in five people will develop cancer in their lifetime. Cancer treatment often involves medications like antimetabolites, alkylating agents, and plant alkaloids, which are widely prescribed. This growing prevalence is driving the demand for pharmaceutical logistics services.
The renowned companies in the pharmaceutical logistics market consist of Cardinal Health Inc, Cencora (AmerisourceBergen), CEVA Logistics, DB Schenker, Deutsche Post AG, and DSV.
Headquartered in Dublin, Ohio, Cardinal Health specializes in manufacturing and distributing medical products, alongside offering pharmaceutical distribution services and data solutions tailored for healthcare facilities. Collaborating with more than 4,500 sourcing and manufacturing partners, the company provides comprehensive solutions and data-driven insights. Catering to a wide spectrum of healthcare needs, Cardinal Health serves over 3.4 million home healthcare patients with a diverse portfolio comprising over 46,000 home healthcare products. The company operates through two primary business segments: pharmaceutical and medical.
Latest from the Company:
In April 2024, Cardinal Health announced the construction of a new 350,000-square-foot logistics center in Columbus, Ohio, to function as a central replenishment center for distributing over-the-counter consumer health products.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the pharmaceutical logistics market revenue growth in North America and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the North America pharmaceutical logistics market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA PHARMACEUTICAL LOGISTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL LOGISTICS MARKET
2.1.1. IMPACT
OF COVID-19
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. LOGISTICS
TYPE
2.3.2. SERVICES
OFFERED
2.3.3. MODE
OF TRANSPORTATION
2.3.4. APPLICATION
2.3.5. REGULATORY
COMPLIANCE
2.3.6. TECHNOLOGICAL
CAPABILITIES
2.3.7. COST
2.3.8. RELIABILITY
2.3.9. AGILITY
2.4. VALUE
CHAIN ANALYSIS
2.4.1. MANUFACTURING
2.4.2. STORAGE
2.4.3. TRANSPORTATION
2.4.4. DISTRIBUTION
2.4.5. MONITORING
COMPONENTS
2.4.6. CONSUMPTION
2.5. REGULATORY
OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
& PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.8. MARKET
DRIVERS
2.8.1. ESCALATING
DEMAND FOR TEMPERATURE-REGULATED SOLUTIONS
2.8.2. EXPANDING
OCEAN FREIGHT SERVICES
2.8.3. INCREASING
CONSUMER INCLINATION TOWARDS OVER-THE-COUNTER MEDICATIONS
2.9. MARKET
CHALLENGES
2.9.1. NECESSITY
FOR REAL-TIME TRANSPARENCY AND DEPENDABILITY
2.9.2. STRINGENT
REGULATORY MANDATES
2.10. MARKET
OPPORTUNITIES
2.10.1. RISING
OPPORTUNITIES IN CELL & GENE THERAPY LOGISTICS DUE TO INCREASED DEMAND
2.10.2. DIGITAL
TRANSFORMATION PAVING THE WAY FOR ADVANCEMENTS IN PHARMACEUTICAL LOGISTICS
2.10.3. GROWING
DEMAND FOR CLINICAL TRIAL LOGISTICS
2.11. ANALYST
PERSPECTIVE
3. NORTH
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY COMPONENT
3.1. STORAGE
3.2. TRANSPORTATION
3.3. MONITORING
COMPONENTS
4. NORTH
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY PHARMA TYPE
4.1. BRANDED
DRUGS
4.2. GENERIC
DRUGS
4.3. OTC
5. NORTH
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY LOGISTICS TYPE
5.1. NON-COLD
CHAIN LOGISTICS
5.2. COLD
CHAIN LOGISTICS
6. NORTH
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY THERAPY AREA
6.1. COMMUNICABLE
DISEASES
6.2. ONCOLOGY
6.3. DIABETES
6.4. CARDIOVASCULAR
DISEASES
6.5. AUTOIMMUNE
DISEASES
6.6. NEUROLOGICAL
DISORDERS
6.7. PAIN
MANAGEMENT
6.8. RESPIRATORY
DISEASES
6.9. OTHER
THERAPY AREAS
7. NORTH
AMERICA PHARMACEUTICAL LOGISTICS MARKET – BY COUNTRY OUTLOOK
7.1. UNITED
STATES
7.1.1. UNITED
STATES PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2. CANADA
7.2.1. CANADA
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AGILITY
LOGISTICS
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. AP
MOLLER – MAERSK
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. CARDINAL
HEALTH INC
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. CENCORA
(AMERISOURCEBERGEN)
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. CEVA
LOGISTICS
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. DB
SCHENKER
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. DEUTSCHE
POST AG
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. DSV
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. FEDEX
CORPORATION
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. KUEHNE
+ NAGEL
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. MARKEN
(ACQUIRED BY UPS)
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. 8KEY
CHALLENGES
8.12. MEDLINE
INDUSTRIES LP
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. SEKO
LOGISTICS
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
8.14. UNITED
PARCEL SERVICE (UPS)
8.14.1. OVERVIEW
8.14.2. PORTFOLIO
8.14.3. KEY
STRENGTHS
8.14.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE 2: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, FORECAST YEARS, 2024-2032
(IN $ MILLION)
TABLE 3: LIST OF CONTRACTS &
PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 9: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 11: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2023 & 2032 (IN %)
FIGURE 5: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $
MILLION)
FIGURE 8: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2023 & 2032 (IN %)
FIGURE 9: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2023 & 2032 (IN %)
FIGURE 13: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 14: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 15: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2023 & 2032 (IN %)
FIGURE 16: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 17: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 19: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 20: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 21: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $
MILLION)
FIGURE 22: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 23: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 24: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $
MILLION)
FIGURE 25: NORTH AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 26: UNITED STATES
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 27: CANADA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)